Pomalidomide-PEG2-OH
CAS No. 2143097-10-1
Pomalidomide-PEG2-OH( 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]- )
Catalog No. M28648 CAS No. 2143097-10-1
Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | 1368 | Get Quote |
|
| 500MG | 2673 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePomalidomide-PEG2-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
-
DescriptionPomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
-
In Vitro——
-
In Vivo——
-
Synonyms1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]-
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP2C9|inflammation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2143097-10-1
-
Formula Weight361.35
-
Molecular FormulaC17H19N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCOCCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Takahashi H, et al. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Drug Metab Dispos. 1999 Oct;27(10):1179-86.
molnova catalog
related products
-
11-Oxomogroside II A...
11-Oxomogroside II A1 (compound 7) is an oxidized cucurbitin. It can be isolated from the ethanol extract of Rohanberry fruit.
-
C-Reactive Protein (...
CRP, an acute phase serum protein synthesized in response to inflammatory cytokines, produces antitumor effects in animals. The fragment CRP (174-185) (RS-83277) shows similar activity by significantly enhancing the tumoricidal activity of human monocytes and alveolar macrophages in vitro.
-
IRL-1620 TFA (142569...
IRL-1620 (TFA) is a potent selective endothelin receptor B (ETB) agonist with a Ki value of 16pm.
Cart
sales@molnova.com